# Bicycle Therapeutics (BCYC) — Earnings

BCYC · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/bcyc/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$1.14 |
| EPS estimate | −$0.95 |
| EPS surprise | −20.48% |
| Revenue surprise | −69.03% |
| Revenue | $2.9M |
| Revenue estimate | $9.4M |
| Reported | Aug 8, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1761612/000155837025010843/bcyc-20250630x10q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 8, 2025 | −$0.95 | −$1.14 | -20.48% | $9.4M | $2.9M |
| Q1 2025 | May 1, 2025 | −$0.84 | −$0.88 | -4.55% | $8.2M | $10.0M |
| Q4 2024 | Feb 25, 2025 | −$0.86 | −$0.75 | 12.46% | $5.4M | $3.7M |
| Q3 2024 | Oct 31, 2024 | −$0.80 | −$0.74 | 7.11% | $6.8M | $2.7M |
| Q2 2024 | Aug 6, 2024 | −$1.11 | −$0.77 | 30.49% | $6.1M | $9.4M |
| Q1 2024 | May 2, 2024 | −$1.25 | −$0.62 | 50.44% | $6.1M | $19.5M |
| Q4 2023 | Feb 20, 2024 | −$1.23 | −$1.16 | 5.95% | $7.0M | $5.3M |
| Q3 2023 | Nov 2, 2023 | −$1.20 | −$1.26 | -4.93% | $12.9M | $5.4M |
| Q2 2023 | Aug 3, 2023 | −$1.20 | −$1.41 | -17.52% | $5.8M | $11.4M |
| Q1 2023 | May 4, 2023 | −$1.08 | −$1.30 | -20.60% | $3.9M | $4.9M |
| Q4 2022 | Feb 28, 2023 | −$1.06 | −$1.01 | 4.62% | $3.6M | $3.2M |
| Q3 2022 | Nov 3, 2022 | −$0.90 | −$0.96 | -6.67% | $5.7M | $3.0M |
| Q2 2022 | Aug 4, 2022 | −$0.85 | −$0.90 | -6.06% | $3.7M | $4.4M |
| Q1 2022 | May 5, 2022 | −$0.68 | −$0.93 | -36.76% | $4.5M | $3.9M |
| Q4 2021 | Mar 1, 2022 | −$0.62 | −$0.63 | -2.36% | $5.5M | $3.8M |
| Q3 2021 | Nov 4, 2021 | −$0.61 | −$0.59 | 3.44% | $5.7M | $4.3M |
| Q2 2021 | Aug 5, 2021 | −$0.71 | −$0.74 | -4.06% | $2.3M | $1.8M |
| Q1 2021 | May 6, 2021 | −$0.71 | −$0.73 | -3.30% | $1.8M | $1.8M |
| Q4 2020 | Mar 11, 2021 | −$0.47 | −$0.83 | -75.66% | $3.7M | $3.8M |
| Q3 2020 | Nov 5, 2020 | −$0.52 | −$0.52 | -0.48% | $2.7M | $3.8M |

## Frequently Asked Questions

### When did Bicycle Therapeutics (BCYC) last report earnings?

Bicycle Therapeutics last reported on Aug 8, 2025, covering fiscal Q2 2025.

### Did BCYC beat earnings estimates?

No. Bicycle Therapeutics reported EPS of −$1.14 for Q2 2025 against a −$0.95 estimate — a 20.48% miss.

### How much revenue did BCYC report last quarter?

Bicycle Therapeutics reported $2.9M in revenue for Q2 2025, against a consensus estimate of $9.4M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).